Sam Gumbert, MD

Appointed
2021

Education & Fellowships

Residency - McGovern Medical School at the Univ of Texas Health Science Ctr at Houston
Anesthesiology
Houston, TX United States
2010

Internship - McGovern Medical School at the Univ of Texas Health Science Ctr at Houston
Otolaryngology
Houston, TX United States
2007

Medical Education - The University of Texas Health Science Center at Houston
Doctor of Medicine
Houston, TX United States
2006

Graduate School - University of Texas at Austin
Audiology
Austin, TX
1999

Undergraduate - University of Texas at Austin
Communication Sciences and Disorders with Special Honors
Austin, TX
1997

Professional Highlights

• American Board of Anesthesiology Oral Board Examiner 2017
• American Board Anesthesiology Part 2 Board Certification Examiner
• Fellow of the American Society of Anesthesiologists (FASA), 2023; Awarded for leadership, contributions, and commitment to patient care, education, and the future of the specialty of anesthesiology

Certifications

• Anesthesiology

Awards & Honors

• Teaching in Excellence Award (Awarded top 15% of school faculty); McGovern Medical School UT Health at Houston, 2010– 2017
• Evan G. Pivalizza Outstanding Clinical Instructor of the Year Award; McGovern Medical School UT Health Department of Anesthesiology 2011– 2012, 2017
• Houstonia Top Doctor Award- Anesthesiologists 2013– 2016
• Faculty of the Year-Trauma Anesthesia 2016; McGovern Medical School UT Health at Houston. Department of Anesthesia
• Academy of Master Educators McGovern Medical School, Inducted 2017;Honorary society recognizing education excellence across all health science disciplines.
• Outstanding Teacher of the Year Award; George Washington University Department of Anesthesiology and Critical Care Medicine, 2020
• Outstanding Mentor of the Year Award; George Washington University Department of Anesthesiology and Critical Care Medicine, 2020
• Association of University Anesthesiologists (AUA), Inducted 2020“; Reflecting strong endorsement of stature as a national leader who has contributed to the advancement of the specialty in academic medicine by their peers and institutions.” AUA members are nominated and elected based on excellence in teaching, administration, and research.
• Cleveland Clinic Physician of the Year Award in General Anesthesia, 2022
• Cleveland Clinic Physician of the Year Award for the Anesthesiology Institute, 2023
• The Giorgio Zanettin MD, Colleague of the Year Award; Cleveland Clinic Multispecialty Anesthesia Institute, 2024
• Cleveland Clinic Multispecialty Anesthesia Physician of the Year Award, 2024
  
  
  

See publications for Sam Gumbert, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 6/26/2024, Dr. Gumbert has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.